Literature DB >> 3360027

Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. III. Cross validation study on depressed patients: the psychotic motor syndrome as a possible state marker for endogenous depression.

W Günther1, R Günther, P Streck, H Römig, A Rödel.   

Abstract

This study investigates the presence and course of motor symptoms in endogenous (n = 42) and non-endogenous (n = 15) depressed patients (both medicated and unmedicated) in comparison to 15 healthy control persons. As in our previous studies on schizophrenic and depressed patients, we used a motor test battery, which consisted of the Motorische Leistungsserie, a modified version of the Lincoln Oseretzky Motor Development Scale and the motor subtest of the Luria Nebraska Neuropsychological Battery. Previous findings had suggested the existence of a psychotic motor syndrome (PMS) in endogenous depressed patients (and schizophrenics), involving disturbances of the lips and tongue, fine and gross movements of the dominant right hand and the complex motor coordination of the extremities. We re-confirmed the PMS in acute endogenous depressed patients, both medicated and unmedicated. Such a motor syndrome did not exist in healthy controls, or in non-endogenous depressed patients, irrespective of the severity of the depressive syndrome. This PMS showed a clear improvement with the amelioration of the depressive symptoms in endogenous depressed patients towards the end of the hospital treatment period and disappeared entirely in patients in a symptom free interval. This may be suggestive of a possible role for the PMS as a state marker for endogenous depression, in contrast to the persistence of the PMS in schizophrenics (trait marker), described previously. The results of factorial analyses on motor performance did not reveal differences in the factorial structure between depressives, schizophrenics and normals. However, they indicated disturbances on a general motor factor, which may account for the performance deficits in psychotic patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3360027     DOI: 10.1007/bf00382369

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  21 in total

1.  Some neurophysiologic aspects of depressed states: an electromyographic study.

Authors:  G B WHATMORE; R M ELLIS
Journal:  AMA Arch Gen Psychiatry       Date:  1959-07

2.  Psychomotor activity in affective states.

Authors:  D J Kupfer; B L Weiss; G Foster; T P Detre; R McPartland
Journal:  Arch Gen Psychiatry       Date:  1974-06

3.  [Self-rating scales for evaluation of patient's subjective state in cross-sectional and longitudinal studies of psychopathology (author's transl)].

Authors:  D von Zerssen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-07-20

4.  Psychomotor function in affective disorders: an overview of new monitoring techniques.

Authors:  J F Greden; B J Carroll
Journal:  Am J Psychiatry       Date:  1981-11       Impact factor: 18.112

5.  Elongation of pause-time in speech: a simple, objective measure of motor retardation in depression.

Authors:  E Szabadi; C M Bradshaw; J A Besson
Journal:  Br J Psychiatry       Date:  1976-12       Impact factor: 9.319

6.  [Psychomotor disorders in psychiatric patients as a possible basis for new approaches in differential diagnosis and therapy. I. Results of initial studies in depressed and schizophrenic patients].

Authors:  W Günther; H Gruber
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

7.  Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. II. Cross validation study on schizophrenic patients: persistence of a "psychotic motor syndrome" as possible evidence of an independent biological marker syndrome for schizophrenia.

Authors:  W Günther; R Günther; F X Eich; E Eben
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

8.  EEG mapping of left hemisphere dysfunction during motor performance in schizophrenia.

Authors:  W Guenther; D Breitling; J P Banquet; P Marcie; P Rondot
Journal:  Biol Psychiatry       Date:  1986-03       Impact factor: 13.382

9.  Facial muscle electromyography in depressed and nondepressed hospitalized subjects: a partial replication.

Authors:  D Oliveau; R Willmuth
Journal:  Am J Psychiatry       Date:  1979-04       Impact factor: 18.112

10.  Decrease in speech pause times with treatment of endogenous depression.

Authors:  J F Greden; B J Carroll
Journal:  Biol Psychiatry       Date:  1980-08       Impact factor: 13.382

View more
  5 in total

1.  Functional motor asymmetries correlated with clinical findings in unmedicated schizophrenic patients.

Authors:  I Gorynia; R Uebelhack
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

2.  Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. Part VI. Evaluation of psychomotor training programs in schizophrenic patients.

Authors:  W Günther; P Streck; N Müller; G R Mair; E Kalischek; W Bender; R Günther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

3.  Instability in functional motor laterality of children and adolescents with endogenous psychosis and predominantly motor disturbances.

Authors:  I Gorynia; U Dudeck; K J Neumärker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

4.  Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. V. Evaluation of psychomotor training programs in depressed patients.

Authors:  W Günther; P Streck; C Haag; U Klages; N Müller; I Hantschk; W Bender; M Gündürewa; R Günther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

5.  Sensory and motor secondary symptoms as indicators of brain vulnerability.

Authors:  Nava Levit-Binnun; Michael Davidovitch; Yulia Golland
Journal:  J Neurodev Disord       Date:  2013-09-24       Impact factor: 4.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.